Search

everythinglearnresearchcommunity

for

Search:↓

Advancements in skin regeneration focus on stem cells, nanotechnology, and bioengineered skin to improve healing and reduce scarring.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Reflectance confocal microscopy helped tell periorificial dermatitis apart from similar skin conditions.

COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Zinc is essential for plant growth and human health, but many soils lack enough zinc, affecting crops and potentially leading to health problems.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Skin symptoms like rashes and sores can indicate COVID-19 severity, especially in older people.

Mothers have more hair proteins than their children, with age-related differences in protein patterns, and some proteins in hair could indicate early childhood development.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

A young boy with Netherton syndrome improved significantly using IVIG, dupilumab, and dietary changes.

People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

PCOS involves immune and genetic factors, with key roles for T cells and specific genes.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Changes in scalp microbes may contribute to hair loss, suggesting new treatment options.

Light-based therapy can help regrow hair in different types of hair loss, but more research is needed.